Daratumumab in transfusion-dependent patients with low or intermediate-1 risk myelodysplastic syndromes

被引：0

作者：

Garcia-Manero, Guillermo ^{[1
]}

Diez-Campelo, Maria ^{[2
]}

Vellenga, Edo ^{[3
]}

Jacoby, Meagan A. ^{[4
]}

Merchan, Brayan ^{[5
]}

Breems, Dimitri ^{[6
]}

Cortelezzi, Agostino ^{[7
,8
]}

Doronin, Vadim ^{[9
]}

Gomez, Valle ^{[10
]}

Beckers, Marielle ^{[11
]}

Della Porta, Matteo Giovanni ^{[12
]}

Varsos, Helen ^{[13
]}

Xiu, Liang ^{[13
]}

DeAngelis, Nikki ^{[14
]}

Nnane, Ivo ^{[14
]}

Rose, Esther ^{[13
]}

van Eygen, Koen ^{[15
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[2] Univ Salamanca, Hosp Clin, Salamanca, Spain

[3] Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, Groningen, Netherlands

[4] Washington Univ, Sch Med, St Louis, MO USA

[5] Vall dHebron Inst Oncol, Barcelona, Spain

[6] Ziekenhuis Netwerk Antwerpen, Antwerp, Belgium

[7] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy

[8] Univ Milan, Milan, Italy

[9] City Clin Hosp 40, Moscow, Russia

[10] Hosp Univ La Princesa, Madrid, Spain

[11] Univ Hosp Leuven, Leuven, Belgium

[12] Humanitas Clin & Res Ctr IRCCS, Humanitas Canc Ctr, Rozzano, Italy

[13] Janssen Res & Dev LLC, Raritan, NJ USA

[14] Janssen Res & Dev LLC, Spring House, PA USA

[15] AZ Groeninge, Kortrijk, Belgium

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2021年 / 96卷 / 04期

关键词：

D O I：

10.1002/ajh.26095

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E111 / E114

页数：4

共 50 条

[1] Discontinuation of Lenalidomide in Patients with Transfusion-Dependent Low- and Intermediate-1 Risk Myelodysplastic Syndromes with Del(5q): Sustained Remissions, but Not Cure
Giagounidis, Aristoteles
Goehring, Gudrun
Haase, Sabine
Aul, Carlo
Schlegelberger, Brigitte
Kuendgen, Andrea
Herbst, Regina
Ehninger, Gerhard
Platzbecker, Uwe
[J]. BLOOD, 2009, 114 (22) : 1464 - 1465
[2] Iron Chelation in Transfusion-Dependent Patients With Low-to Intermediate-1-Risk Myelodysplastic Syndromes RESPONSE
Angelucci, Emanuele
Greenberg, Peter
Izquierdo, Miguel
Garcia-Manero, Guillermo
[J]. ANNALS OF INTERNAL MEDICINE, 2020, 173 (07) : 595 - 596
[3] A randomized controlled trial comparing darbepoetin alfa doses in red blood cell transfusion-dependent patients with low- or intermediate-1 risk myelodysplastic syndromes
Jun Ho Jang
Hironori Harada
Hirohiko Shibayama
Ryutaro Shimazaki
Hyeoung-Joon Kim
Kenichi Sawada
Kinuko Mitani
[J]. International Journal of Hematology, 2015, 102 : 401 - 412
[4] A randomized controlled trial comparing darbepoetin alfa doses in red blood cell transfusion-dependent patients with low- or intermediate-1 risk myelodysplastic syndromes
Jang, Jun Ho
Harada, Hironori
Shibayama, Hirohiko
Shimazaki, Ryutaro
Kim, Hyeoung-Joon
Sawada, Kenichi
Mitani, Kinuko
[J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2015, 102 (04) : 401 - 412
[5] Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes A Randomized Trial
Angelucci, Emanuele
Li, Junmin
Greenberg, Peter
Wu, Depei
Hou, Ming
Montano Figueroa, Efreen Horacio
Guadalupe Rodriguez, Maria
Dong, Xunwei
Ghosh, Jagannath
Izquierdo, Miguel
Garcia-Manero, Guillermo
[J]. ANNALS OF INTERNAL MEDICINE, 2020, 172 (08) : 513 - +
[6] Cardiac iron overload in transfusion-dependent patients with myelodysplastic syndromes
Roy, Noemi B. A.
Myerson, Saul
Schuh, Anna H.
Bignell, Patricia
Patel, Roger
Wainscoat, Jim S.
McGowan, Simon
Marchi, Emanuele
Atoyebi, Wale
Littlewood, Tim
Chacko, Joseph
Vyas, Paresh
Killick, Sally B.
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2011, 154 (04) : 521 - 524
[7] Quality of life measurement in patients with transfusion-dependent myelodysplastic syndromes
Jansen, AJG
Essink-Bot, ML
Beckers, EAM
Hop, WCJ
Schipperus, MR
van Rhenen, DJ
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2003, 121 (02) : 270 - 274
[8] IMerge: A phase 3 study to evaluate imetelstat in transfusion-dependent subjects with IPSS low or intermediate-1 risk myelodysplastic syndromes that are relapsed/refractory to erythropoiesis-stimulating agent treatment.
Platzbecker, Uwe
Komrokji, Rami S.
Fenaux, Pierre
Zeidan, Amer Methqal
Sekeres, Mikkael A.
Savona, Michael R.
Madanat, Yazan
Sherman, Laurie Jill
Dougherty, Souria
Sun, Libo
Huang, Fei
Wan, Ying
Rizo, Aleksandra
Berry, Tymara
Feller, Faye
Santini, Valeria
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[9] LEVELS OF TRANSFUSION BURDEN AND ASSOCIATED COSTS FOR PATIENTS WITH TRANSFUSION-DEPENDENT MYELODYSPLASTIC SYNDROMES
DeZern, A. E.
Binder, G.
Rizvi, S.
Corvino, F. A.
Arikian, S. R.
Surinach, A.
Lee, J.
Smith, B. D.
[J]. HAEMATOLOGICA, 2016, 101 : 245 - 245
[10] Observational Monitoring of Patients with Aplastic Anemia and Low/Intermediate-1 Risk of Myelodysplastic Syndromes Complicated with Iron Overload
Du, Yali
Long, Zhangbiao
Chen, Miao
Han, Bing
Hou, Bo
Feng, Feng
[J]. ACTA HAEMATOLOGICA, 2017, 138 (02) : 119 - 128

← 1 2 3 4 5 →